Drugs / IL-YANG Quadrivalent Influenza Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03445468 | Sep → Dec 2017 | influenza | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02677493 | Oct 2015 → Jan 2016 | influenza | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IL-YANG Quadrivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02677493 ↗ |
| Modality | Vaccine | “IL-YANG Quadrivalent Influenza Vaccine Inj.” NCT02677493 ↗ |
| Route | Intramuscular | “A single 0.5mL dose administrated as an intramuscular injection.” NCT02677493 ↗ |